# Assessment of 14-3-3 η (Eta) Protein Antibodies in the Serum of Rheumatoid Arthritis Patients and Its Relation to Atherosclerosis.

> **NCT04937140** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 140 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DIAGNOSTIC_TEST:** 14-3-3 η (eta) protein antibodies in the serum of rheumatoid arthritis patients

## Key facts

- **NCT ID:** NCT04937140
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2022-08
- **Final completion:** 2022-09
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2021-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937140, "Assessment of 14-3-3 η (Eta) Protein Antibodies in the Serum of Rheumatoid Arthritis Patients and Its Relation to Atherosclerosis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*